CytoMed Therapeutics Ltd (GDTC) stock
GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.78+0.01 (+1.18%)
Close on Nov 17, 2026Market cap $9.26MP/E –Yield –
CytoMed Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was -1227.1%, against -3621.1% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1227.1% | +2394.0 |
| FY2024 | Dec 31, 2024 | -3621.1% | – |
See a number that looks wrong?